Free Trial
NASDAQ:BBNX

Beta Bionics (BBNX) Stock Price, News & Analysis

Beta Bionics logo
$14.96 +0.66 (+4.62%)
As of 04:00 PM Eastern

About Beta Bionics Stock (NASDAQ:BBNX)

Key Stats

Today's Range
$13.97
$15.06
50-Day Range
$12.53
$19.55
52-Week Range
$8.89
$24.50
Volume
362,386 shs
Average Volume
488,975 shs
Market Capitalization
$648.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$23.44
Consensus Rating
Moderate Buy

Company Overview

Receive BBNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Beta Bionics and its competitors with MarketBeat's FREE daily newsletter.

BBNX Stock News Headlines

Bitcoin Beats Gold — But This Coin Could Beat Them Both
Bitcoin just hit a record high—but it’s not the top crypto play right now. Crypto analyst Juan Villaverde, who called Bitcoin’s breakout to $100K nearly to the day, says a lesser-known coin could be even bigger. It’s faster, cheaper, and backed by Google, Visa, and top VCs with over $200 million already invested.
See More Headlines

BBNX Stock Analysis - Frequently Asked Questions

Beta Bionics' stock was trading at $23.81 at the beginning of the year. Since then, BBNX shares have decreased by 37.8% and is now trading at $14.82.

Beta Bionics, Inc. (NASDAQ:BBNX) posted its quarterly earnings data on Tuesday, May, 6th. The company reported ($0.52) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.51) by $0.01.
Read the conference call transcript
.

Beta Bionics (BBNX) raised $204 million in an IPO on Thursday, January 30th 2025. The company issued 12,000,000 shares at $17.00 per share.

Beta Bionics's lock-up period expires on Tuesday, July 29th. Beta Bionics had issued 12,000,000 shares in its IPO on January 30th. The total size of the offering was $204,000,000 based on an initial share price of $17.00. After the expiration of the company's lock-up period, company insiders and major shareholders will be able to sell their shares of the company.

Beta Bionics' top institutional investors include Palumbo Wealth Management LLC (0.07%). Insiders that own company stock include Hadley Harbor Aggre Wellington, Mike Mensinger, Steven Jon Russell, Stephen Feider and Mark Hopman.
View institutional ownership trends
.

Shares of BBNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/06/2025
Today
7/22/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:BBNX
Previous Symbol
NASDAQ:BBNX
CIK
1674632
Web
N/A
Fax
N/A
Employees
294
Year Founded
N/A

Price Target and Rating

High Price Target
$30.00
Low Price Target
$16.00
Potential Upside/Downside
+60.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
12 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
15.88
Quick Ratio
14.93

Sales & Book Value

Annual Sales
$65.12 million
Price / Sales
9.71
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($5.72) per share
Price / Book
-2.55

Miscellaneous

Outstanding Shares
43,360,000
Free Float
N/A
Market Cap
$632.19 million
Optionable
N/A
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:BBNX) was last updated on 7/22/2025 by MarketBeat.com Staff
From Our Partners